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Clinical efforts to repair damaged articular cartilage (AC) currently face major obstacles due to limited
intrinsic repair capacity of the tissue and unsuccessful biological interventions. This highlights a need for
better therapeutic strategies. This review summarizes the recent advances in the ﬁeld of cell-based AC
repair. In both animals and humans, AC defects that penetrate into the subchondral bone marrow are
mainly ﬁlled with ﬁbrocartilaginous tissue through the differentiation of bone marrow mesenchymal
stem cells (MSCs), followed by degeneration of repaired cartilage and osteoarthritis (OA). Cell therapy
and tissue engineering techniques using culture-expanded chondrocytes, bone marrow MSCs, or
pluripotent stem cells with chondroinductive growth factors may generate cartilaginous tissue in AC
defects but do not form hyaline cartilage-based articular surface because repair cells often lose chon-
drogenic activity or result in chondrocyte hypertrophy. The new evidence that AC and synovium develop
from the same pool of precursors with similar gene proﬁles and that synovium-derived chondrocytes
have stable chondrogenic activity has promoted use of synovium as a new cell source for AC repair. The
recent ﬁnding that NFAT1 and NFAT2 transcription factors (TFs) inhibit chondrocyte hypertrophy and
maintain metabolic balance in AC is a signiﬁcant advance in the ﬁeld of AC repair. The use of synovial
MSCs and discovery of upstream transcriptional regulators that help maintain the AC phenotype have
opened new avenues to improve the outcome of AC regeneration.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
An acute cartilage or osteochondral defect may be caused by a
comminuted or displaced intra-articular fracture, while a chronic
articular cartilage (AC) defect is often a result of AC degradation
during the progression of osteoarthritis (OA). Another cause of
osteochondral defects that is relatively rare is osteochondritis dis-
secans (OCD), a joint disease with osteonecrosis of the subchondral
bone usually linked to antecedent trauma, which occurs most often
in the knee of young men and athletes1e3. The link between AC
damage and OA is undeniable, making the pursuit of clinical
advancement in the area of cartilage regeneration of paramount
importance. Unlike spontaneous OA, which mostly affects middle-
aged and older populations, cartilage injury-induced post-J. Wang, University of Kansas
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ternational. Published by Elsevier Ltraumatic OA (PTOA) often affects younger adults for whom desir-
able treatment is to preserve the function of the original joint by
regenerating damaged AC instead of joint replacement or
arthrodesis. This highlights a great need for earlier, less invasive
treatment modalities for both acute and chronic AC lesions.
Manynew lines of treatment forACdefects have become available
over the past ﬁve decades with even more animal models on the
verge of clinical trial, yet our understanding of how AC heals remains
insufﬁcient to support any given line of therapy over another. Most
cartilage repair techniques have been based on a postulate that a
substance, such as a graft, scaffold, or mesenchymal-cell-rich blood
clot, must be interposed in order for an AC defect to be repaired. This
is based onmany years of success gained from the general art of using
grafts to ﬁll defects in the skin and bone. Unfortunately, grafting
techniques for AC regenerationhave not been as successful as for skin
or bone regeneration.
The major breakthroughs in AC repair began in 1959 when
Pridie published his drilling method for AC resurfacing in osteoar-
thritic knee joints noting that accessing the underlying bone
marrow led to a clot formation which had the potential to formtd. All rights reserved.
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et al. who coined the term microfracture as a method of accessing
the bone marrow with a bone pick without the potentially harmful
effects of drilling. A clinical follow-up revealed that 80% of the
patients had signiﬁcant improvement in joint function and pain5.
However, it has become clear that the ﬁbrocartilage-like repair
tissue with hypertrophic chondrocytes generated by the bone
marrow stimulation procedure was less than optimal for long term
outcomes6,7.
Osteochondral allografting was also being used during this time
period and remains in use today for the treatment of large cartilage
defects in young, high-demand patients in whom total joint
arthroplasty was a poor option. Transplantation of mature hyaline
cartilage into the affected area is an advantage of the procedure.
However, disease transmission, immunological response, and the
long-term viability of transplanted allografts are concerns with any
allografting procedure. Graft nonunion and fragmentation may
occur from months to years after the procedure8,9. Osteochondral
autografting (mosaicplasty) affords the same advantages without
the risk of disease transmission or immunologic response, but it is
limited by donor site availability and morbidity. Short- (<5 years)
and medium-term (5e9 years) clinical outcomes showed that pa-
tients with osteochondral defects treated with mosaicplasty
maintain a superior level of athletic activity compared with those
treated withmicrofracture. However, long-term (>10 years) clinical
outcome after mosaicplasty varies greatly depending on the age,
gender, and size of the lesions10,11.
In 1987, it was reported that chondrocytes could be cultured and
implanted into chondral defects that had not disrupted the sub-
chondral bone12. Soon thereafter Brittburg and Peterson et al.
published their ﬁrst case series describing a new method of treat-
ment termed autologous cartilage transplantation, later referred to
as autologous chondrocyte implantation (ACI)13. Subsequent follow
up studies, however, have failed to demonstrate a signiﬁcant dif-
ference in structural repair at 24 months in randomized controlled
clinical trials comparing ACI to microfracture14e17.
Tissue engineering techniques for cartilage or osteochondral
repair have gained a signiﬁcant amount of interest over the past
two decades. This technology involves three main components:
biomaterial-based scaffolding, a cell source, and growth or differ-
entiation factors. Scaffolds for repair of osteochondral defects may
be fabricated with natural (e.g., collagen) or synthetic materi-
als18e21. Cell sources include isolated autologous chondrocytes,
minced autologous cartilage, multipotent stem cells (e.g., bone
marrow-, muscle-, synovium-, or adipose-derived mesenchymal
cells), pluripotent stem cells, and induced pluripotent stem cells
(iPSC)16,18,19,22e26. Chondroinductive growth factors mainly consist
of members of the transforming growth factor-b (TGF-b) super-
family, insulin-like growth factor-1 (IGF-1), and speciﬁc members
of ﬁbroblast growth factor (FGF) family. These growth factors have
been used for stimulating chondrogenic differentiation of stem
cells in cell culture or through controlled release, gene trans-
duction/delivery, or nanoparticle delivery16,25,27e30. Bioreactors are
utilized to enhance nutrient delivery and provide mechanical
stimulation to tissue-engineered cartilage constructs ex vivo prior
to in vivo implantation.
While cell-based therapies (e.g., microfracture, ACI) are already
in clinical use for promotion of AC repair, none of these options
have been proven successful in restoring the original AC structure
with hyaline cartilage in humans16,17. Clinicians and scientists are
striving for a better understanding of cartilage healing process in
order to develop more reliable methods of AC repair. Here, we re-
view the recent advances in cell-based therapies for AC repair, with
a focus on the latest development in synovial mesenchymal stem
cells (MSCs) as a cell source and novel TFs that may serve aspotential upstream regulators for maintaining the permanent hy-
aline cartilage phenotype of healing AC and preventing PTOA.
Current challenges
Cartilage remains one of the most difﬁcult tissues to heal.
Several approaches including tissue engineering have been devel-
oped in the past decades to regenerate damaged AC; however, none
of these approaches have been proven to effectively produce a
repair tissue with the same or similar mechanical and functional
characteristics of the native AC. At a cellular level the challenges we
currently face in AC regeneration fall into at least two major
categories:
1. Chondrocyte differentiation problems including insufﬁcient chon-
drogenic differentiation, chondrocyte dedifferentiation, and chon-
drocyte hypertrophy: Although chondroinductive growth factors
may induce the differentiation of various stem cells into chon-
drocytes, the induction process may not be sufﬁcient to produce
functional chondrocytes. Autologous chondrocytes have shown
the most promise in this regard but may undergo dedifferentia-
tion to ﬁbroblast-like cells during the ex vivo expansion or in vivo
repair process. As a result, an AC defect site may be ﬁlled with
ﬁbrous tissue or ﬁbrocartilage-like repair tissue instead of the
desirable AC containing hyaline cartilage that is uniquely orga-
nized into a complex, layered structure and physiologically tightly
regulated. One of the key limitations to engineered cartilage tis-
sues is that it is amorphous and lacks the three-dimensional or-
ganization and structural properties of native AC, thereby
rendering it susceptible to physical and physiological stresses. On
the otherhand, it has beenobserved that bonemarrowMSCshave
an intrinsic differentiation program reminiscent of endochondral
bone formation31. Some repair chondrocytes may undergo hy-
pertrophic differentiation, followed by matrix calciﬁcation,
vascular invasion, and endochondral ossiﬁcation leading to new
bone formation in an AC defect site. Because of these drawbacks
researchers are searching for better repair techniques which can
induce differentiation of stem cells into functional, matrix pro-
ducing articular chondrocytes with less potential for dedifferen-
tiation or hypertrophic differentiation.
2. Cartilage homeostasis problems characterized by imbalanced
anabolic and catabolic cellular activity of repair cells: In the acute
post-traumatic phase, joint trauma may lead to suppression of
collagen and proteoglycan synthesis in AC. Remaining viable
cells in joint tissues may respond to the injury with enhanced
synthetic activity and overexpression of matrix-degrading en-
zymes and inﬂammatory mediators. During the healing of AC
defects, cytokines and enzymes released by synoviocytes and
chondrocytes in and around the repair tissue are required in
order to initiate the repair process and eventually integrate the
repair tissue within the defect. However, overexpression of
catabolic factors may cause an imbalance between anabolic and
catabolic activities at the defect site, leading to cartilage
degradation, failed repair, and subsequent PTOA2,32. Therefore,
the chondrocyte homeostasis in the defect is critical for the
quality of healing cartilage and the integration of repair cartilage
with the existing AC and subchondral bone. In addition, articular
chondrocytes respond physiologically to both chemical33e35 and
mechanical36e39 stimuli. This responsiveness could explain in
part the late degradation of repair tissue which is initially
hyaline-like but degenerates over time.
In order to overcome these challenges, researchers have been
searching for new cell sources for AC repair by studying the link
between the development and regeneration of AC and exploring
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lating both anabolic and catabolic activities of articular
chondrocytes.
The link between development and regeneration
While much focus has been placed on the central inductive
postulate of ﬁlling an AC defect with a repair material (e.g., grafting
technique, bone marrow stimulation), less attention has been paid
to the more basic deductive thought that the art of AC regeneration
might link to the processes of joint development. Theoretically, if
we could inﬂuence the body to repeat the processes of develop-
ment in the setting of an injury, we would cure the problem of AC
injury. In order to do this several questions must be answered,
however. First, it is necessary to have a better understanding of
where the cells for the formation of joint tissues come from. Sec-
ond, it is important to investigate the speciﬁc processes of AC for-
mation. Many authors both from the remote past as well as the near
present have contributed to this study40e47. Each facet of joint
development constitutes an item of extensive discussion
throughout the literature40e43,46e53. Here we will take a deeper
look into some of these areas, with a focus on the formation of the
subchondral bone, AC, and synovium.
Development of the secondary ossiﬁcation center (SOC) and
subchondral bone
The mid-shaft (diaphysis) of a long bone develops by endo-
chondral ossiﬁcation through the development of the primary
ossiﬁcation center (POC). The bone tissue at the ends of the
developing POC constitutes the metaphysis54.
The cartilaginous epiphysis begins to take shape at each end of
the diaphysis just before or after birth (depending on the speciﬁc
epiphysis) both in humans andmammalian animals54,55. The SOC is
formed in the proximal and distal ends of the cartilage model
shortly after birth. The initial structural change in the development
of the SOC is that chondrocytes within the center of the epiphyseal
cartilage become hypertrophic. The matrix adjacent to the hyper-
trophic chondrocytes then mineralizes and is invaded by vessels
of the cartilage canals carrying mesenchymal cells and
preosteoblasts54e56.
Early in the postnatal phase, much of the epiphyseal cartilage is
replaced by bone and bone marrow via endochondral ossiﬁcation.
Continuous ossiﬁcation leads to the expansion of trabecular bone
and formation of the subchondral bone plate54,55. Taken together,
these developmental studies have conﬁrmed that both POC and
SOC including the subchondral bone plate and bone marrow
develop through the endochondal sequence of ossiﬁcation.
Development of the AC and synovium
During the late-stage of long bone development, the SOC grows
outward, and the surrounding epiphyseal cartilage becomes
thinner54,55. This raises the question of whether or not the articular
surface represents a remnant epiphyseal cartilage which has un-
dergone transformation to permanent cartilage, or perhaps the
remaining epiphyseal cartilage is resorbed and replaced by a new
tissue which forms the articular surface.
Both human and animal studies suggest that a special cell
population called “interzone cells” may be involved in the forma-
tion of synovial joint. Gardner et al. proposed that the formation of
three-layered interzones begins in most joints during the fetal
period in humans44. Holder reported that removal of the interzone
area of tissue results in fusion of bone segment with no sign of joint
formation in chicks41.A study of rat joint formation by Mitrovic suggested that inter-
zone cells are responsible for formation of joint tissues and struc-
tures, including AC, ligaments, and synovial lining, while the joint
capsule appears to be derived from a distinct condensation57.
Subsequent studies suggested that interzone cells from the outer
layers differentiate into chondrocytes early in embryogenesis and
become incorporated into the epiphysis, thus contributing to initial
lengthening of the anlagen. A subset of interzone cells from the
intermediate layer become articular chondrocytes and other intra-
articular tissue cells42,58,59. Recent genome-wide gene expression
analyses on interzone cells isolated from mouse embryos at 15.5
days support this conclusion by showing a higher gene expression
level relevant to chondrocyte hypertrophy and endochondral
ossiﬁcation in the outer layer than the intermediate layer60. Other
studies, however, seem to support the idea that the interzone may
originate from a distinctly separate subpopulation of cells, which
are different from those predestined for endochondral ossiﬁcation
of the diaphysis48,61. The potential regulatory factors for interzone
cell differentiation and joint formation have been described in a
comprehensive review48.The role of chondrogenic progenitor cells in postnatal development
of AC
Hunziker et al. examined postnatal development and matura-
tion of AC in rabbits from the ﬁrst to the eighth month. They
concluded that AC is reorganized by a process of tissue resorption
and neoformation, rather than by internal remodeling62. However,
the origin of the chondrogenic progenitor cells was not elucidated
in that study.
Simkin later proposed that articular chondrocyte stem cells
originate in an area he refers to as the “marginal transitional
zone” where the AC meets synovium and periosteum at the pe-
ripheral margins of the joint63. In mature AC, MSCs continue to
arrive at the joint margins and then descend into the deeper
zones but no further division occurs. The resultant depot for
apoptotic chondrocyte debris forms the histological feature of the
tidemark between uncalciﬁed and calciﬁed cartilage63. This hy-
pothesis is particularly interesting as it seems to parallel the
ﬁndings regarding the origin and travel of interzone cells, sug-
gesting that the embryonic pattern of AC development continues
throughout postnatal development and even into adulthood.
However, experimental analyses are required to validate these
hypotheses.
While adult AC is considered an avascular, aneural, and
alymphatic tissue with little capacity for self-repair after injury,
several studies have identiﬁed chondrogenic progenitor cells in
the superﬁcial zone of normal and osteoarthritic AC in animals
and humans51,62,64e67. However, the function of the progenitor
cells in AC repair during the adult stage needs to be further
elucidated.
Although enormous amounts of debate persist and questions
about whether the AC is contrived entirely of interzone cells or
formed by other cell populations are still open for discussion, it is
clear by now that the SOC and subchondral bone including its bone
marrow are developed via the endochondral sequence of ossiﬁca-
tion. It is also clear that normal epiphyseal cartilage is transient/
temporal cartilage in which chondrocytes undergo hypertrophic
differentiation and endochondral ossiﬁcation. In contrast, the dif-
ferentiation of articular chondrocytes in normal AC (permanent
cartilage) is halted at the matrix producing stage, and they do not
undergo hypertrophic changes or endochondral ossiﬁcation. The
proposed tissue origins of AC, synovium, and subchondral bone are
illustrated in Fig. 1.
Fig. 1. A diagram showing proposed mechanisms for the development of major joint tissues. Upper panels: The interzone is distinguishable into a central intermediate zone and
two outer layers contiguous to the epiphyseal ends. Interzone cells from the intermediate layer contribute to the formation of AC, synovial lining, and intra-articular ligaments.
Interzone cells from the outer layers differentiate into chondrocytes and become incorporated into the epiphysis, which undergoes endochondral ossiﬁcation. Dotted arrows
indicate that further elucidation is required. Lower panels: The development of the SOC begins with the formation of cartilage canal containing blood vessels, followed by
chondrocyte hypertrophy and endochondral ossiﬁcation in the center of the epiphyseal cartilage.
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The chondrogenic potential of synovium-derived MSCs and
their application in AC repair have been studied in vitro and
in vivo68e75. An early in vitro study demonstrated that human
multipotent MSCs can be isolated from the synovial membrane of
knee joints. These cells have the ability to proliferate extensively in
culture and maintain their multilineage differentiation potential in
cultures, establishing their progenitor cell nature76. Subsequent
studies revealed that human synovial MSCs have greater expansion
and chondrogenic ability in vitro than MSCs from bone marrow,
periosteum, muscle, and adipose tissue77. The weight of cartilagi-
nous pellets from cultured mouse synovial MSCs is signiﬁcantly
greater than that from cultured bone marrowMSCs68. Extracellular
matrix deposited by synovial MSCs delays replicative senescent
chondrocyte dedifferentiation and enhances redifferentiation73.
Another important rationale for the use of synovial MSCs for AC
repair is that synovial MSC-derived chondrocytes and articular
chondrocytes share similar gene expression proﬁle. Synovial MSCs-
mediated tissue engineered cartilage matrix is deposited with
collagen-II and aggrecan but not collagen-I or collagen-X and is
mechanically similar to AC. Moreover, synovial MSCs express a
speciﬁc proteoglycan (superﬁcial zone protein), a functional char-
acteristic of progenitor cells in the superﬁcial zone of AC. Gene
expression proﬁles revealed that chondrogenic progenitor cells
from the superﬁcial zone of AC and synovial cells are closely
related67,77e80. Thus, synovial MSCs may be particularly useful in
regenerating the superﬁcial layer of AC.
AC or osteochondral repair with synovial MSCs has also been
demonstrated in animal studies. Transplantation of synovialMSCs into full-thickness osteochondral defects of adult rabbits
resulted in cartilage formation in the defect but some trans-
planted MSCs differentiated into bone cells in the deep zone,
suggesting that synovial MSCs may differentiate into different
lineage cells according to local microenvironments81. Several
more recent animal studies further conﬁrmed the repair process
of AC defects using synovium-derived MSCs with or without
scaffolds69,71,72,74.
In 2011, Sekiya et al. reported arthroscopic transplantation of
synovial MSCs for the treatment of AC defects in humans. Regen-
eration of cartilage, reduction in defects size, and improvement of
symptoms were observed in most patients over the 3-year study82.
Synovial response to AC damage
Hunziker et al. studied partial-thickness AC defects (without
disruption of subchondral bone) in adult rabbit knees and found
that the source of cells for repair was either within the synovium or
in the subsynovial space83. It was suggested that these cells trav-
eled along the articular surface until they found their way into the
defect. These ﬁndings would not refute evidence supporting the
idea that stem cells reside in the articular surface but would clarify
where they originate and, furthermore, disclose where theymay be
housed in adulthood. Kurth et al. reported the existence of resident
MSCs in the knee joint synovium that undergo proliferation and
chondrogenic differentiation following joint-surface injury in
mice70.
Most recently, we observed chondrogenic differentiation of
MSCs in the synovium after the creation of osteochondral defects in
the patellofemoral joint groove of adult mice. Cartilage formation is
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which the repair cells are derived from subchondral bone marrow
(Fig. 2, unpublished data).
Regulation of adult AC homeostasis: the role of NFAT signaling
Imbalance of metabolic activities at the AC defect site
Proper balance of anabolic and catabolic activities is critical for
the maintenance of AC integrity and the regeneration of AC dam-
age. PTOA occurs when the equilibrium between breakdown and
repair of the joint tissues becomes unbalanced84e86. A chondral or
osteochondral defect may occur after severe joint injuries such as
displaced articular fractures. Even with the best current care of
joint injuries, such as anatomic reduction and rigid ﬁxation of intra-
articular fractures and reconstruction of ruptured ligaments with
successful restoration of joint biomechanics, the risk of PTOA afterFig. 2. Photomicrographs of a representative mouse patellofemoral joint with an osteoch
patellofemoral joint received sham surgery (arthrotomy only, right) at 6 weeks after surgery
Top left: A patellofemoral joint with an osteochondral defect (arrow) and chondrocyte diffe
left: A micrograph enlarged from the yellow box in the top left panel shows the differentiatio
plica. Bottom left: A micrograph with higher magniﬁcation shows that the osteochondral de
ﬁbrous tissue in the upper defect. Top right: A patellofemoral joint that received sham surge
synovial plica (open arrow) enlarged from the black box in the top right panel shows norma
distal femur without an osteochondral defect shows essentially normal AC and subchondrajoint injuries ranges from 20% to more than 50%2,87. These clinical
studies suggest that biological factors may be involved in the
development of PTOA.
Immediate effects of joint trauma include structural damage to
joint tissues, hemarthrosis, and death of articular chon-
drocytes32,88. The lubricating properties of the synovial ﬂuid is
compromised as a result of the dilution of synovial ﬂuid by intra-
articular bleeding and plasma extravasation, leading to lower
concentrations of hyaluronic acid and lubricant. In the acute post-
traumatic phase, joint trauma may lead to suppression of
collagen and proteoglycan synthesis in AC. Remaining viable cells in
joint tissues may respond to the injury with enhanced synthetic
activity and overexpression of matrix-degrading enzymes and in-
ﬂammatory mediators89e91. Initial cell necrosis is followed by a
subsequent spreading of cell death mediated by apoptotic mecha-
nisms, which occurs beyond the initial area into surrounding
unimpacted regions. During the healing of AC damage, cytokinesondral defect created in the patellar groove of the distal femur (left) and a mouse
. Cartilage is stained in red. Six mice from each group were evaluated at this time point.
rentiation in the synovium that is attached to the joint margins (arrowheads). Middle
n of synovial cells into chondrocytes (arrowhead) forming new cartilage in the synovial
fect (arrow) is ﬁlled with new cartilage cells (red) in the lower portion of the defect and
ry shows a normal synovial plica (open arrow in the black box).Middle right: A normal
l synovial lining and subsynovial ﬁbrous tissue. Bottom right: A patellar groove of the
l bone. Safranin-O and fast green staining, counterstained with haematoxylin.
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around the repair tissue may cause an imbalance between anabolic
and catabolic activities, leading to cartilage degradation and sub-
sequent PTOA88,91. Therefore, the chondrocyte homeostasis in the
healing defect is critical for the quality of healing cartilage and the
integration of repair cartilage with the original AC and subchondral
bone.
NFAT1 and NFAT2 regulate metabolic activities of articular
chondrocytes and suppress chondrocyte hypertrophy
NFAT (nuclear factor of activated T cells) is a family of TFs
originally identiﬁed as regulators of gene transcription in response
to T-cell receptor-mediated signals in lymphocytes. Currently, ﬁve
members of the NFAT family have been identiﬁed: NFAT1 (NFATc2/
NFATp), NFAT2 (NFATc1/NFATc), NFAT3 (NFATc4), NFAT4 (NFATc3/
NFATx), and NFAT5. With the exception of NFAT5, which is ubiq-
uitously expressed and activated in response to osmotic stress,
nuclear translocation and activation of NFAT1-4 proteins are
induced by the Ca2þ-calmodulin-dependent phosphatase
calcineurin92e95. Early studies reported NFAT1 as a regulator of the
expression of cytokine genes during the immune response; mice
lacking NFAT1 displayed an enhanced immune response96,97.
However, the in vitro effects of speciﬁc NFAT members on chon-
drocyte function have been controversial. An early study suggested
that NFAT4 induces chondrogenesis, which is an anabolic effect98,
while other studies reported that NFAT1 promotes ADAMTS-4
expression and NFAT2 (NFATc1) activates ADMTS-9 in chon-
drocytes, which are catabolic effects99,100.
Our recent in vivo studies demonstrated thatmice lacking NFAT1
exhibit normal skeletal development but display most of the fea-
tures of human OA in adults101,102. Expression of multiple pro-
inﬂammatory cytokines (e.g., IL-1b, IL-6, IL-17a) and matrix-
degrading proteinases (e.g., MMP1a, MMP13, ADAMTS5) is signif-
icantly up-regulated in AC and synovium of adult Nfat1/ mice,
while expression of speciﬁc anabolic factors such as BMP-2, -5, -7,
-10, -11, -12, and -13 as well as IGF-1, TGF-b1, -b2, and -b3 is
signiﬁcantly down-regulated in the AC of adult Nfat1/mice101,102.
NFAT1 binding sites were identiﬁed in the genes for speciﬁc cata-
bolic and anabolic factors, such as IL-1b, TNF-a, MMP-13, ADMTS-5,
BMP-7, TGF-b1, and Collagen-2, -9, 10, and -11. Our chromatin
immunoprecipitation (ChIP) assays have conﬁrmed the binding of
NFAT1 protein to the promoter of these genes in articular chon-
drocytes of adult mice103. These new ﬁndings suggest that NFAT1
regulates the expression of multiple catabolic and anabolic mole-
cules in AC and is a key TF for maintaining the homeostasis of AC in
adult mice. Nfat1 deﬁciency causes OA mainly due to an imbalance
between catabolic and anabolic activities of articular chondrocytes
with dysfunction of peri-articular tissue cells, particularly synovial
cells.
A more recent study by Greenblatt et al. supports our conclu-
sion. The authors investigated the role of NFATc1 (NFAT2) and
NFATc3 (NFAT4) in AC biology104. NFATc1 was previously identiﬁed
as a regulator of cardiac development and osteoclast differentia-
tion105,106. They found that Nfatc1 mRNA expression is reduced in
lesional AC from human OA patients. Since cartilage-speciﬁc Nfatc1
mutant (Nfatc1col2) or Nfatc3 mutant (Nfatc3col2) mice did not
display any phenotypic differences compared to wild type mice,
Nfatc1col2 or Nfatc3col2 mice were intercrossed with Nfatc2 (Nfat1)
null allele to generate double mutant mice. Nfatc2/Nfatc3col2
mice displayed no additional abnormalities beyond those seen in
Nfatc2/ mice, whereas Nfatc2/Nfatc1col2 mice displayed severe
cartilage degradation with subluxation of the elbow at 1 week of
age and of the metatarsals at 3 weeks of age. At the molecular level,these double mutant mice exhibited increased expression of genes
encoding many matrix-degrading proteinases, along with the hy-
pertrophic chondrocyte marker collagen X. At the same time,
expression of Sox9 and lubricin were reduced in the Nfatc2/
Nfatc1col2 mutants104. These results suggest that NFAT1may play a
more important role than NFAT2 in the maintenance of AC ho-
meostasis and prevention of OA.
To evaluate the effect of NFAT1 deﬁciency on the healing of AC,
the authors of this review have recently developed a new mouse
model of cartilage repair by surgical creation of an osteochondral
defect in the patellar groove of the distal femur of Nfat1/ and
wild-type (WT) mice. Although osteochondral defects were ﬁlled
with repair cartilaginous tissue in bothWTandNfat1/mice, more
hypertrophic chondrocytes and endochondral ossiﬁcation were
observed in Nfat1/ defects than in WT defects. The expression of
mRNA for type-10 collagen and speciﬁc pro-inﬂammatory cyto-
kines and matrix-degrading proteinases was up-regulated in
Nfat1/ defects compared with WT defects. At 26 weeks after
surgery, WT mice showed mild to moderate early-stage OA in the
patellofemoral joints, while Nfat1/ mice displayed severe late-
stage OA in the patellofemoral joints with segmentation of repair
tissue and severe incongruity of the articular surfaces107. In addi-
tion, more severe osteoarthritic cartilage lesions were seen in the
knee joints of Nfat1/ mice than WT mice after destabilizing the
medial meniscus108.
These in vivo studies have provided strong evidence that NFAT1
suppresses chondrocyte hypertrophy and catabolic metabolism
during the healing of cartilage lesions, thereby attenuating the
progression of PTOA. The proposed mechanisms by which NFAT1
suppresses the development of OA are illustrated in Fig. 3.
Future perspectives
Although many strategies could improve the outcome of AC
repair, our perspectives will focus on cell-based repair of AC and
osteochondral lesions.
Optimization of scaffolds and mechanical loading to improve cell
migration, proliferation and differentiation
Development of novel scaffolds that mimic the inherent
gradient structure of healthy osteochondral tissue might improve
cellular activity in tissue engineering-mediated AC repair. For
example, a gradient scaffold may consist of a bone layer composed
of type I collagen and beta-tricalcium phosphate (TCP) or hy-
droxyapatite (HA), an intermediate layer composed of type I
collagen, type II collagen and TCP/HA, and a cartilaginous region
composed of type II collagen and hyaluronic acid20,109,110. Reﬁne-
ment of the chemical and material properties of scaffolds may
improve the biological cues required for inﬁltration and prolifera-
tion of MSCs or chondrocytes in scaffolds, while the biomechanical
properties of an optimized scaffold may provide an environment to
promote differentiation of stem cells towards the required lineage
in each region. The inclusion of bioactive factors in gradient-based
scaffolding may further improve the outcome of osteochondral
defect repair.
Mechanical factors play a signiﬁcant role in the maintenance of
the chondrocyte phenotype as chondrocytes are known to lose
their chondrocyte speciﬁc phenotype when removed from their
native ECM for monolayer culture, resembling prechondrocytic
MSCs but regain chondrocyte phenotype when placed into a three-
dimensional culture (i.e., agarose gel) for continued culture111e113.
Chondrocytes harvested from adult, human AC do not demonstrate
the same need for chemical induction in order to form new AC;
Fig. 3. An illustration demonstrates that catabolic and anabolic factors that may be responsible for the development of OA and the possible role of NFAT1 in preventing the initiation
or attenuating the progression of OA.
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into the transient phenotype in monolayer culture12. Appropriate
mechanical loading on the joint with healing AC may be beneﬁcial
to the formation of hyaline cartilage and congruity of articular
surfaces.
Synovial MSCs as a cell source for AC repair
Perhaps the deﬁciencies we have encountered so far with
bone marrow stimulation techniques are due to the fact that bone
marrow MSCs may not be the best cell source or may require
speciﬁc modulation for the healing of AC damage. Future di-
rections would include a deeper look into the potential function
of synovial MSCs, thereby discovering functional distinctions they
may have from bone marrow MSCs and mature articular
chondrocytes.
As described above, synovial MSCs could be a new cell source for
better AC repair because synovium and AC develop from the same
pool of precursor cells, synovium is attached to AC in adulthood and
synovial MSCs actively respond to AC damage, the gene proﬁle of
AC cells more closely matches that of synovial cells than bone
marrow MSCs, and chondrogenic potential of synovial cells for AC
repair has been demonstrated in animal models and preliminary
clinical trials. Some techniques need to be further reﬁned. For
example, two different types of synoviocyte cells, macrophage-like
(type A) and ﬁbroblast-like (type-B) cells, should be distinguished
by speciﬁc techniques. Type A cells function in innate and adaptive
immunity, while type B cells contribute to the formation of synovial
ﬂuid and are believed to be the source of synovial MSCs70,114,115.
Reproducible methods for isolation and identiﬁcation of speciﬁc
type B synoviocytes from experimental animals and humans need
to be optimized.
Use of upstream regulators of chondrocyte differentiation and
cartilage homeostasis
The molecular mechanisms that lead to regeneration and
maintenance of AC structure and function would be of tremendous
therapeutic value, especially noting that degenerating repair
cartilage seems to demonstrate the hypertrophic and endochondral
phenotype (i.e., type X collagen expression)31. Tissue engineering
offers the possibility of promoting anabolic and inhibiting catabolic
activity in AC repair by adding an anabolic growth factor or anti-
catabolic agent. One of the major reasons for the failure of carti-
lage tissue engineering would be that multiple anabolic and cata-
bolic factors are involved in the healing of cartilage lesions88e91;
thus, one or more chondrogenic growth factors currently used for
cartilage tissue engineering is unlikely to sufﬁciently modulate thehealing process in long-term. Furthermore, OA is a multifactorial
disease; genetic modiﬁcations of one of susceptible factors may
precipitate OA-like changes in mice. Many factors are involved in
the pathogenesis of OA, including aging, genetic factors, matrix-
degrading proteinases, pro- and anti-inﬂammatory cytokines,
growth factors, and hormones. Therefore, upstream regulatory
factors such as TFs that regulate multiple anabolic and catabolic
molecules would be more desirable for the regeneration of AC and
prevention of PTOA.
A number of TFs have been reported to play a role in chon-
drocyte differentiation and cartilage homeostasis during the
development and adulthood. SOX9 is critical for chondrocyte
differentiation and cartilage morphogenesis during skeletal
development116. SOX9 and SOX trio (SOX-5, 6, and-9) may pro-
mote cartilage repair in osteochondral defects117. However, over-
expression of SOX9 is unable to restore the chondrocyte
phenotype in dedifferentiated osteoarthritic chondrocytes118, and
postnatal inactivation of Sox9 in mouse cartilage does not result in
OA by 18 months of age119. The RUNX family proteins, RUNX1-3,
play important roles in skeletal development and repair. RUNX1
is required for differentiation of chondroprogenitor cells and
promotes cartilaginous callus formation during fracture heal-
ing120. RUNX2 (Cbfa1) is required for chondrocyte maturation and
osteoblast differentiation, and deletion of RUNX2 results in a
complete lack of bone formation121,122. RUNX2 enhances sub-
chondral bone formation during the healing of osteochondral
defects123. RUNX3 regulates chondrocyte differentiation and
promotes cartilage formation during fracture healing124. RUNX3-
deﬁcient mice display severe limb ataxia125. Somatic deletion of
the b-catenin (a key transcriptional activator of the canonical Wnt
pathway) gene results in lethality before formation of the skeletal
elements126. Conditional deletion of the b-catenin gene in early
mesenchymal progenitor cells leads to enhanced chondro-
genesis127. Both gain- and loss-of-function of b-catenin in AC
resulted in similar OA-like phenotypes128,129. b-Catenin expres-
sion is up-regulated in AC of young adult Nfat1/ mice, at which
time some Nfat1/ hip joints began to show early OA-like
changes102. The role of increased b-catenin in Nfat1 deﬁciency-
induced OA remains to be elucidated. C-maf plays a role in both
chondrocyte differentiation and homeostasis130,131.
Table I summarizes the roles of above-mentioned TFs and
NFAT1-2 in cartilage biology and pathology. Except NFAT1, global or
conditional gene deletion of all these factors results in severe
developmental defects in the skeletal system. NFAT1 appears to be
one of the few, if not the sole, TFs that speciﬁcally regulate the
function of articular chondrocytes in the adult, but not in the
developmental stage. Since TFs usually serve as upstream regula-
tors of multiple catabolic and anabolic genes, appropriate use of a
Table I
Selected transcription factors (TFs) in chondrocyte differentiation and skeletal homeostasis/repair
TF Developmental defect in skeleton by mutation Role in adult cartilage/bone Ref#*
SOX9 Yes. Required for chondrocyte differentiation and cartilage
formation
Promoting anabolic activity and repair of AC 116e119
RUNX1 Yes. Required for differentiation of chondroprogenitor cells into
the chondrogenic lineage
Promoting cartilaginous callus formation during
fracture healing
120
RUNX2 (Cbfa1) Yes. Required for chondrocyte maturation and osteoblast
differentiation
Enhancing subchondral bone formation in
osteochondral repair
121e123
RUNX3 Yes. Regulating chondrocyte terminal differentiation, limb
ataxia in Runx3-deﬁcient mice
Promoting cartilage formation during fracture healing 124,125
b-caty Yes. Required for skeletal development, promoting
osteogenesis and inhibiting chondrogenesis
Regulating homeostasis of AC and bone formation 126e129
c-Maf Yes. Required for normal chondrocyte differentiation Activating MMP-13 gene expression in OA AC 130,131
NFATc1 (NFAT2) Yes. Required for cardiac development, defective joint
formation in double mutant mice lacking NFATs c1 and c2 in
cartilage
Regulating chondrocyte function, bone formation, and
terminal differentiation of osteoclasts in bone marrow
cells
104e106
NFATc2 (NFAT1) No. Not required for skeletal development, no developmental
defects in skeleton of Nfat1-deﬁcient mice
Suppressing OA, chondrocyte hypertrophy in AC, and
PTOA after cartilage injury in Nfat1-deﬁcient mice
101e104, 107,108
* Ref# ¼ Reference number cited in this article.
y b-cat ¼ b-catenin.
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growth factor or anti-catabolic cytokine for the regeneration of AC
and prevention of PTOA.
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